Camu, William
Hôpital Necker-Enfants Malades · Cleveland Clinic · Inserm · Université de Lille · Universitat de Girona · Hospital Universitari Arnau de Vilanova · Centre Hospitalier Universitaire de Lille · Humboldt-Universität zu Berlin · AB Science (France) · Jena University Hospital · Hospital Universitari de Girona Doctor Josep Trueta · Institut des Maladies Génétiques Imagine · Lille Neurosciences & Cognition · Freie Universität Berlin · Charité – Universitätsmedizin Berlin
9 papers on CoChatORCID 0000-0003-1287-7355
Most cited papers
- Verified
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics
Amyotrophic Lateral Sclerosis ResearchHereditary Neurological Disorders
Cited by 1,544
- Verified
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet
Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling
Cited by 942
- Verified
Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis
Camu, W., Tremblier, B., Plassot, C., Alphandery, S., Salsac, C., Pageot, N., Juntas-Morales, R., Scamps, F., Daures, J.-P., & Raoul, C. (2014) · Neurobiology of Aging
Amyotrophic Lateral Sclerosis ResearchVitamin D Research Studies
Cited by 95
- Verified
Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis
Moulard, B., Sefiani, A., Laamri, A., Malafosse, A., & Camu, W. (1996) · Journal of the Neurological Sciences
Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments
Cited by 93
- Verified
Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance.
Grimaldi-Bensouda, L., Rossignol, M., Koné-Paut, I., Krivitzky, A., Lebrun-Frenay, C., Clet, J., Brassat, D., Papeix, C., Nicolino, M., Benhamou, P.-Y., et al. (2017) · Journal of Autoimmunity
Cervical Cancer and HPV ResearchPharmacovigilance and Adverse Drug Reactions
Cited by 84
- Verified · note
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
Vermersch, P., Brieva-Ruiz, L., Fox, R. J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O., Maciejowski, M., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research StudiesPolyomavirus and related diseases
Cited by 74
- Verified
Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis
Bowerman, M., Vincent, T., Scamps, F., Perrin, F. E., Camu, W., & Raoul, C. (2013) · Frontiers in Cellular Neuroscience
Amyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration Mechanisms
Cited by 46
- Verified
UBQLN2 mutations are rare in French and French–Canadian amyotrophic lateral sclerosis
Daoud, H., Suhail, H., Szuto, A., Camu, W., Salachas, F., Meininger, V., Bouchard, J.-P., Dupré, N., Dion, P. A., & Rouleau, G. A. (2012) · Neurobiology of Aging
Amyotrophic Lateral Sclerosis ResearchHereditary Neurological Disorders
Cited by 42
- Verified
Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis
Millecamps, S., Corcia, P., Cazeneuve, C., Boillée, S., Seilhean, D., Danel-Brunaud, V., Vandenberghe, N., Pradat, P.-F., Le Forestier, N., Lacomblez, L., et al. (2012) · Neurobiology of Aging
Amyotrophic Lateral Sclerosis ResearchHereditary Neurological Disorders
Cited by 40
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free